Significant Ownership of Deep Track Capital, LP

Signature - Title
/s/ David Kroin - David Kroin, Managing Member of the General Partner of the Investment Adviser
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Deep Track Capital, LP.

Notify me when Deep Track Capital, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Deep Track Capital, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share 15% 3,352,804 Deep Track Capital, LP 12 Sep 2025
VSTM Verastem, Inc. Common stock, $0.0001 par value per share 10% $60,288,436 7,719,390 Deep Track Capital, LP 14 Nov 2025
CMPS COMPASS Pathways plc American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share 10% $34,965,201 9,274,589 Deep Track Capital, LP 10 Jan 2025
PMN ProMIS Neurosciences Inc. Common Shares, no par value per share 10% $6,137,415 902,561 Deep Track Capital, LP 30 Jan 2026
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 10% $4,568,300 2,366,995 Deep Track Capital, LP 12 Aug 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 9.9% $12,280,920 14,116,000 Deep Track Capital, LP 23 Dec 2024
MAZE Maze Therapeutics Inc. Common Stock, $0.001 par value per share 9% $59,431,096 +$13,927,661 3,948,910 +31% Deep Track Capital, LP 30 Jun 2025
CNTX Context Therapeutics Inc. Common Stock, $0.001 par value per share 8.3% $7,419,355 7,419,355 Deep Track Capital, LP 31 Mar 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.3% $12,137,760 13,486,400 Deep Track Capital, LP 08 Jan 2026
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 7.2% $63,580,000 +$15,895,000 5,500,000 +33% Deep Track Capital, LP 31 Mar 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 7.1% $178,290,000 +$38,453,587 3,000,000 +27% Deep Track Capital, LP 30 Sep 2025
MNMD Mind Medicine (MindMed) Inc. Common Shares 6.9% $64,845,000 -$11,790,000 5,500,000 -15% Deep Track Capital, LP 30 Sep 2025
ENTA ENANTA PHARMACEUTICALS INC Common Stock, par value $0.01 per share 6.8% $25,263,153 +$6,098,090 1,956,867 +32% Deep Track Capital, LP 31 Dec 2025
ENGN enGene Holdings Inc. Common Shares 6.7% $30,048,631 +$14,462,734 4,317,332 +93% Deep Track Capital, LP 11 Nov 2025
MBX MBX Biosciences, Inc. Common Stock, $0.0001 par value per share 6.6% $28,604,897 2,188,592 Deep Track Capital, LP 30 Jun 2025
MLTX MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share 6.5% $33,054,209 4,610,071 Deep Track Capital, LP 05 Nov 2025
CRMD CorMedix Inc. Common stock, $0.001 par value 6.3% $55,204,125 4,955,487 Deep Track Capital, LP 21 Nov 2025
IVA Inventiva S.A. Ordinary shares, nominal value 0.01 EUR per share 6.1% $53,618,977 11,668,983 Deep Track Capital, LP 23 Jan 2026
GPCR Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value 6% $855,579,599 -$21,646,354 12,335,346 -2.5% Deep Track Capital, LP 31 Dec 2025
IMVT Immunovant Inc. Common Stock, $0.0001 par value per share 5.6% $144,590,000 9,500,000 Deep Track Capital, LP 19 Mar 2025
APLS Apellis Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 5.6% $125,720,000 7,000,000 Deep Track Capital, LP 09 May 2025
Definium Therapeutics, Inc. Common Shares 5.5% 5,676,540 Deep Track Capital, LP 31 Dec 2025
OCUL Ocular Therapeutix, Inc Common Stock, $0.0001 par value per share 5.1% $132,787,440 +$23,640,000 11,234,132 +22% Deep Track Capital, LP 05 Feb 2026
GERN Geron Corp Common Stock, $0.001 par value 5.1% $42,914,878 -$13,845,122 32,511,271 -24% Deep Track Capital, LP 31 Dec 2025
BCAX Bicara Therapeutics Inc. Common Stock, $0.0001 par value 5% $48,207,500 2,750,000 Deep Track Capital, LP 05 Feb 2026
ABVX Abivax SA Ordinary Shares (represented by American Depository Shares) 4.8% $28,885,195 3,480,144 Deep Track Capital, LP 30 Jun 2025
HELP CYBIN INC. Common Shares, no par value 4.7% $18,486,334 -$5,262,159 2,391,505 -22% Deep Track Capital, LP 31 Dec 2025
SWTX Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.6% $160,025,357 3,460,756 Deep Track Capital, LP 31 Dec 2024
ORKA Oruka Therapeutics, Inc. Common stock, $0.001 Par Value 4.5% $65,515,368 +$8,023,966 2,161,510 +14% Deep Track Capital, LP 31 Dec 2025
GH Guardant Health, Inc. Common Stock, $0.00001 Par Value 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
OKUR Onkure Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.1% $1,330,932 523,989 Deep Track Capital, LP 31 Dec 2024
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 3% $111,762,000 -$154,160,600 3,150,000 -58% Deep Track Capital, LP 31 Dec 2025
KRRO Korro Bio, Inc. Common stock, par value $0.001 per share 3% $3,638,575 277,966 Deep Track Capital, LP 30 Jun 2025
PTGX Protagonist Therapeutics, Inc Common Stock, par value $0.00001 2.8% $113,973,353 -$101,924,147 1,715,691 -47% Deep Track Capital, LP 30 Sep 2025
VRDN Viridian Therapeutics, Inc. Common Stock, $0.01 par value per share 2.6% $80,163,448 2,524,833 Deep Track Capital, LP 31 Dec 2025
BCYC Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share 2.4% $9,625,952 -$12,943,416 1,203,244 -57% Deep Track Capital, LP 30 Jun 2025
INO INOVIO PHARMACEUTICALS, INC. Common Stock, $0.001 par value 2.4% $3,076,623 1,314,796 Deep Track Capital, LP 30 Sep 2025
FDMT 4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share 1.3% $1,982,175 609,900 Deep Track Capital, LP 31 Dec 2024
NKTR Nektar Therapeutics Common Stock, par value $0.0001 1.1% $1,462,239 1,975,998 Deep Track Capital, LP 31 Dec 2024
AUTL Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share 0.97% $4,186,839 2,568,613 Deep Track Capital, LP 30 Sep 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 0.4% $3,713,262 110,448 Deep Track Capital, LP 31 Dec 2025
ZURA Zura Bio Ltd Class A Ordinary Shares, $0.0001 par value 0.4% $1,121,531 -$18,867,975 259,014 -94% Deep Track Capital, LP 30 Sep 2025
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 -$2,386,791 0 -100% Deep Track Capital, LP 30 Jun 2025
IVVD Invivyd, Inc. Common stock, par value $0.0001 per share 0% $0 -$10,694,479 0 -100% Deep Track Capital, LP 30 Sep 2025
IMA IMAGENEBIO, INC. Common Stock, $0.001 par value 0% $0 -$5,938,768 0 -100% Deep Track Capital, LP 31 Dec 2025
ETNB 89bio, Inc. Common stock, par value $0.001 per share 0% $0 -$126,886,520 0 -100% Deep Track Capital, LP 31 Dec 2025
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 0% $0 -$19,224,879 0 -100% Deep Track Capital, LP 31 Dec 2025
IKNA Ikena Oncology, Inc. Common Stock, $0.001 par value 0% $0 -$2,666,444 0 -100% Deep Track Capital, LP 28 Jul 2025
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP 31 Dec 2024
TECX Tectonic Therapeutic, Inc. Common Stock $0.0001 par value per share 0% $0 -$21,996,407 0 -100% Deep Track Capital, LP 30 Sep 2025
JBIO Jade Biosciences, Inc. Common Stock, $0.0001 par value per share 0% $0 -$31,599,303 0 -100% Deep Track Capital, LP 31 Dec 2025
EDIT Editas Medicine, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Deep Track Capital, LP 31 Dec 2024
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$5,842,754 0 -100% Deep Track Capital, LP 30 Sep 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP 30 Jun 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 0 Deep Track Capital, LP 31 Dec 2024
AKRO Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$178,786,520 0 -100% Deep Track Capital, LP 31 Dec 2025
DNTH Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value 0% $0 -$92,775,574 0 -100% Deep Track Capital, LP 30 Sep 2025
DVAX Dynavax Technologies Corporation Common Stock, $0.001 par value 0% $0 -$247,218,206 0 -100% Deep Track Capital, LP 10 Feb 2026
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 par value 0% $0 0 Deep Track Capital, LP 30 Sep 2025
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 -$99,119,162 0 -100% Deep Track Capital, LP 31 Dec 2025

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.